Cost-Effectiveness of Dapagliflozin Versus Dpp-4 Inhibitors...

Value in Health 2014 / 11 Vol. 17; Iss. 7

Cost-Effectiveness of Dapagliflozin Versus Dpp-4 Inhibitors as Monotherapy in the Treatment of Type 2 Diabetes Mellitus From A Uk Health Care Perspective

Charokopou, M., Vioix, H., Verheggen, B., Eddowes, L.A., Griffiths, M., Gabriel, Z., Tolley, K., Franks, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2014.08.709
Date:
November, 2014
File:
PDF, 62 KB
english, 2014
Conversion to is in progress
Conversion to is failed